Literature DB >> 18664152

Oral erythromycin is ineffective in the treatment of pityriasis rosea.

Iqbal A Bukhari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18664152

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


× No keyword cloud information.
  4 in total

1.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

2.  Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability.

Authors:  Anupam Das; Amrita Sil; Nilay Kanti Das; Kunal Roy; Amal Kanti Das; Debabrata Bandyopadhyay
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

Review 3.  Clinical variants of pityriasis rosea.

Authors:  Francisco Urbina; Anupam Das; Emilio Sudy
Journal:  World J Clin Cases       Date:  2017-06-16       Impact factor: 1.337

Review 4.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.

Authors:  Khushbu Mahajan; Vineet Relhan; Aditi Kochhar Relhan; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.